|
SoCalBio Resources
|
|
Looking for an IP or
business transaction lawyer?
|
|
Use SoCalBio-affiliated law
firms. Click here to see
directory. |
|
Featured SoCalBio Member
A
west Los Angeles-based provides metabolic
profiling and phenotyping services to
pharmaceutical, biotech and research
organizations involved in drug discovery
and development and in the analysis of
disease states ... Learn
more |
|
Become a Member
Join well-known entrepreneur Alfred
Mann and other SoCalBio leaders to
promote the biotech and device industries
in the Greater Los Angeles Metro Area
for job creation and overall economic
growth.
|
 |
|
|
| Past
SoCalBio Events |
|
Thanks to Participants in the Oct.
23 Networking Forum Focusing on
Outsourcing
Vytas
Pazemenas, President & CEO of the Aubrey Group (Right)
engages Chris Robertson of Kythera Biopharmaceuticals (middle)
and Max Sidner of Vincent Medical (left)
in a discussion about the dos and don'ts of
outsourcing in the current economic
environment
|
| Coming
Soon |
|
SoCalBio
Networking Forum
November 20, 2008
4:00 pm - 7:00 pm
UCLA Faculty Club
Event Focus
Can Medtech
and Biotech Weather the Current Economic
Turmoil?
Recent studies contend that
-- notwithstanding the worldwide credit
slowdown that has stalled public-equity
financing -- the medtech industry's
fundamentals are strong and key drivers,
such as the aging populations, the spread
of chronic conditions and an expected
surge in demand for companion diagnostics
for use with new generations of targeted
therapeutics, will fuel
industry's growth in the coming years.
Others contend that -- with a complicated
regulatory environment, changes in patent
law, and fast technological change --
the medtech industry is going
through a period of growing pains that may
result in a slow down. Join us to
participate in a discussion about the
future of the medtech industry as a job
growth driver throughout the U.S., in
general, and in the Greater Los Angeles
region, in particular.
|
| From
The Lab Bench |
UCLA Develops Safer, More
Effective TB Vaccine for People with HIV
UCLA team led by Marcus Horwitz (photo
right), principal investigator and
professor of medicine and microbiology,
immunology and molecular genetics, David
Geffen School of Medicine at UCLA, is
developing the vaccine which, though
could be administered to anyone, is
specifically designed to be given to
HIV-positive newborns and adults whose
immune systems are still relatively intact
and are therefore able to mount a good
immune response to the vaccine, including
persons on antiretroviral therapy... Read more
-
UCSB Researchers Develop
Cross-Protective Vaccine
In a paper published in the November
edition of the journal Infection and
Immunity, UCSB scientists Douglas
Heithoff and Michael Mahan (photo right)
-- along with University of Utah
scientists Elena Enioutina, Diana Bareyan,
and Raymond Daynes -- describe the
path to creating a vaccine that confers
protection against multiple strains of
bacteria ... Read more
-
Caltech
Scientists Engineer Supersensitive
Receptor, Gain Better Understanding of
Brain's Dopamine System
Caltech scientists Henry Lester (photo
right), Bren Professor of Biology, and
Ryan Drenan, senior postdoctoral scholar
in biology, worked with colleagues from
Caltech, the University of Colorado at
Boulder, the Rockefeller University, the
University of Utah, and the pharmaceutical
company Targacept identified a receptor
that may be good target for treatment
of smoking addiction, ADHD, and other
disorders. Read more
-
UCI Breaks Ground on New
Stem Cell Building
The four-story, 100,636-square-foot
building will house the UCI Sue and Bill Gross
Stem Cell Research Center, dozens of
laboratory-based and clinical researchers,
a stem cell techniques course, a master's
program in biotechnology with an emphasis
on stem cell research, and programs and
activities for patients and public
education. The building is scheduled for
completion in July 2010 ... Read more
|
| Market
Trends |
Cash-Poor Biotech Firms
Cut Research, Seek Aid
Although fares better by comparison to
other industries, the biotechnology sector
is shaken by the global financial
crunch which threatens to slow the
development of new medicines and cut
high-tech jobs in the U.S. and Europe ... Read more
Over the last 12 months, the providers of
breast implants, anti-wrinkle products and
liposuction equipment have traded below
the Amex Pharmaceutical index of large
drug companies .. Read article
-
Medicare Battle Looms as
Costs Keep Climbing
Democratic lawmakers in Congress are
girding for a major battle over Medicare
next year that could result in substantial
changes, including cuts in payments to
private insurers that offer Medicare
coverage. A key question in Congress,
where polls show Democrats gaining seats
in next week's election, is whether
Medicare will be dealt with alone or as
part of a wider health-care overhaul....Read more
|
|
Local Company Headlines
|
|
Tech Transfer:
Studies
& Clinical Trials:
Product
Development & Marketing:
Personnel:
Out of
Business:
|
| Bioscience
Industry GIS Profiles |
|
Browse
the SoCalBio Directory of Bioscience Firms
in Greater Los Angeles and Neighboring
Communities
|
| Do
you know? |
|
To enroll, contact Chris Mellgren,
Business Development Manager, Office Depot
Business Solutions Division at
562-490-9139 (Office), 714-749-0849
(Cell), or chris.mellgren@officedepot.
com
For more information about the SoCalBio
Group Purchasing Program,
call 213-236-4890 or send e-mail
to scbc@socalbio.org
|
| About
SoCalBio |
 SoCalBio membership links
you to partners, contract manufacturers,
regulatory and legal experts, and policy
makers. The organization's programs help
emerging biotech and medical device
companies grow. Membership is affordable
-- as low as $500 -- and offers access to
networking opportunities, advocacy,
discounts through our group purchasing
program group purchasing program and
other benefits you simply can't find
elsewhere ... Join SoCalBio
|
| Editor: Ahmed A. Enany
Southern California Biomedical Council
(SoCalBio)
|
|
|